Partial List of 2019 Attendees

• Senior Project Leader, Ablynx a Sanofi Co</<p>

• VP Cellular Immunology, Agenus Inc

• Scientist, Agenus Switzerland Inc

• Scientist, Agenus UK Ltd

• Senior Scientist, Alligator Bioscience AB

• Director, Alligator Bioscience AB

• CTO, Altimmune UK Ltd

• Director Research & Early Development Lead Oncology, Amgen Research Munich GmbH

• CEO & COO & CSO, Antikor Biopharma Ltd

• CSO & Executive VP & Founder, Aratinga Bio Inc

• Founder & CEO, Aratinga Bio Inc

• Senior Scientist, Ardigen SA

• Business Development Manager, Ardigen SA

• Research Fellow, Astellas Pharma Inc

• Principal Scientist, AstraZeneca

• Director Oncology Research, AstraZeneca

• Associate Director Translational Sciences, AstraZeneca

• Assay Scientist, Avacta Life Sciences Ltd

• Instructor, Beth Israel Deaconess Medical Center

• Product Manager, Bio Techne Ltd

• Senior VP & CSO & Managing Director, BioAgilytix Europe

• Researcher, BIOCAD

• Scientist, BIOCAD

• Medical Director Medical Affairs, BIOCAD

• Director, Biocytogen

• Business Development Manager, Biocytogen

• Marketing Associate, Biocytogen Boston Corp

• Project Leader, Biologie Servier

• CSO, Biomunex Pharmaceuticals

• Senior VP & Head, Bristol Myers Squibb Co

• VP Scientific Operations, Caprion Biosciences Inc

• Professor of Immunology, Cardiff University

• Professor, Catholic University of Korea

• Senior Process Development Scientist, Cell & Gene Therapy Catapult

• Chief Clinical Officer, Cell & Gene Therapy Catapult

• Head, Cell & Gene Therapy Catapult

• Chairman & CEO, Cellectis Inc

• Director, Celyad

• Global Head, Celyad Inc

• Graduate Student, Charite University of Medicine

• Professor, Chungnam Natl University

• Senior Editor, Clarivate Analytics

• Associate Director, CMED Grp UK

• CEO, Cordes Biotech AS

• Senior Director Non Clinical Safety, Covagen AG

• Head, CRISPR Therapeutics

• VP Global Quality & Scientific Excellence, Crown Bioscience Inc

• Director Business Development, Definiens AG

• Scientist, Definiens AG

• Director Sales & Business Development, Definiens AG

• VP Business Development, Discovery Life Sciences Inc

• CEO, DNAtrix Inc

• Professor, Dublin City University

• Senior Editor, EBioMedicine

• CEO & CSO, Elasmogen Ltd

• Full Professor, ETH Zurich

• Senior Scientist, F Hoffmann La Roche AG

• Scientist, F star Biotechnology Ltd

• Research Associate, F star Biotechnology Ltd

• VP Business Development, FIMECS Inc

• Senior Research Scientist, Fred Hutchinson Cancer Research Ctr

• Lead Scientist, GE Healthcare UK Ltd

• Principal Scientist, Genentech Inc

• Manager, Genetic Engineering & Biotechnology News

• Corporate VP, Genmab

• Senior Scientist, Genmab BV

• VP Transgenic Technologies, genOway

• Group Leader, German Cancer Research Ctr DKFZ

• Group Leader Medical & Translational Oncology, German Cancer Research Ctr DKFZ

• Expert Scientist, GlaxoSmithKline

• Scientific Leader, GlaxoSmithKline

• Scientist, GLYCOTOPE GmbH

• Director & Professor, Gustave Roussy Institute

• Head, Hadassah Hebrew Univ Hospital

• Director Business Development, Harbour BioMed

• Graduate Student, Hebrew University Jerusalem

• Clinical Professor & Director Cancer Immune Therapy, Herlev Hospital

• Founder & CEO & Managing Director, HOT Screen GmbH

• Lab Head Advanced Cell Models Lab, iBET Instituto de Biologia Experimental Tecnologica

• Professor, Icahn School of Medicine at Mount Sinai

• Medical Science Liaison, Idera Pharmaceuticals Inc

• Field Medical Manager, Idera Pharmaceuticals Inc

• Project Leader, Idorsia Pharmaceuticals Ltd

• CMO, IGM Biosciences Inc

• Senior Scientist & Head, Immuneed AB

• COO, Immuneed AB

• Business Development, Immuneed AB

• Head, Immunocore Ltd

• Founder & CTO, ImmunXperts SA

• Co Founder, Individual Consultant

• Professor, Inje University

• CEO & CMO, INmuneBio Inc

• Engineer, Innate Pharma

• Manager, Innate Pharma

• Director Sales, INOVOTION

• Head, Institut Curie

• Professor, Institute of Cancer Research

• CEO, IntoCell

• Director, Invus SAS

• Analyst, Invus SAS

• Head, IO Biotech ApS

• Associate Director, IsoPlexis

• European Sales Manager, IsoPlexis

• Director European Sales, IsoPlexis

• Research Scientist, iTeos Therapeutics SA

• Director Europe Business Development, Jackson Lab

• VP External Research & Business Development, Kadmon Holdings Inc

• Student, KAIST

• Head Gene & Cell Therapy Grp, Karolinska Institute

• Reader & Head Cancer Antibody Discovery, Kings College London

• Senior PostDoc Scientist, Kings College London

• Graduate Student, Kingston University

• Professor & Director, Klinikum Darmstadt

• VP Immuno Oncology, Kymab Ltd

• Science & Business Liaison, Legend Biotech Ireland Ltd

• Global Head, Lonza Cologne GmbH

• CSO & Director Project Mgmt, MaSTherCell

• Assistant Professor, Mayo Clinic & Foundation

• Surgical Oncologist & Associate Professor, Mayo Clinic & Foundation

• Director Preclinical Studies, Medicago Inc

• Head, Medigene AG

• Executive Medical Dir & Head of Companion Diagnostics, Merck & Co Inc

• Scientist, Merck KGaA

• Account Manager, Merck Millipore UK Ltd

• Senior VP Global Clinical Development & CMO, Merck Research Labs

• Director, MERCK SHARP & DOHME

• Scientific Liaison, Merck Sharp & Dohme Sweden AB

• Senior Medical Assessor, MHRA

• Senior Non Clinical Assessor, MHRA

• Business Development & Program Manager, MI mAbs

• Product Manager, MilliporeSigma

• Principal R&D Scientist, MilliporeSigma

• CEO, multimmune GmbH

• Professor, Natl Univ of Quilmes

• Senior Scientist, Nektar Therapeutics Inc

• Scientist, Nouscom SRL

• Lab Head, Novartis Institutes for BioMedical Research

• Global Program Medical Director, Novartis Pharma AG

• Scientist, NovImmune SA

• CEO & Advisor, nxt2b

• Program Director Discovery, Oncodesign SA

• Lab Director Cellular Pharmacology, Oncodesign SA

• Research Tech, Oslo University Hospital

• Postdoc Fellow, Oslo University Hospital

• Engineer, Oslo University Hospital

• Graduate Student, Oslo University Hospital

• Senior Scientist, Ottawa Health Research Institute

• Lab Head, Peter MacCallum Cancer Ctr

• Director In Vivo Pharmacology & Oncology, Pfizer Inc

• Associate Professor, Prince of Wales Hospital

• Immunology Sales Specialist, ProImmune Ltd

• Principal Scientist, Prokarium

• Project Leader, Protisvalor

• CEO, PsiOxus Therapeutics Ltd

• Head, PsiOxus Therapeutics Ltd

• Director Sales, RareCyte Inc

• Assoc Dir Immune & Inflammatory Diseases, Regeneron Pharmaceuticals Inc

• PostDoc Fellow, Regeneron Pharmaceuticals Inc

• Senior Staff Scientist, Regeneron Pharmaceuticals Inc

• CEO & Founder, Replimune Ltd

• Molecular Biologist, RGCC Intl GmbH

• Head Functional Characterization, Roche Innovation Ctr Penzberg

• Head, Roche Innovation Ctr Zurich

• Head of Oncology Discovery Pharmacology, Roche Innovation Ctr Zurich

• Senior Scientist, Roche Innovation Ctr Zurich

• Team Leader, Roche Innovation Ctr Zurich

• Head of Research, San Raffaele Scientific Institute

• Associate Professor, Southampton General Hospital

• Professor, St Georges Hospital

• Founder & CEO, Straximm Therapeutics Inc

• Founder & CSO, Straximm Therapeutics Inc

• Project Director, Symphogen AS

• Senior Researcher, Sysmex Corp

• Sr Sci, SystImmune Inc

• CEO, SystImmune Inc

• Associate Professor, Taipei Medical Univ

• CMO & Head, Targovax ASA

• Student, Technical University Munich

• Senior Product Mgr, Thermo Fisher Scientific

• Founder & CEO, TILT Biotherapeutics Ltd

• Exec VP Pharmaceutical R&D, Tocagen

• Project Manager, Trans Hit Biomarkers Inc

• CSO & Executive VP R&D, Transgene SA

• Sales Manager, Ultivue Inc

• Sales & Marketing Director, Ultivue Inc

• Clinical Research Training Fellow, University College London

• Professor, University Hospital Tuebingen

• Group Leader, University Medical Ctr Freiburg

• Professor & Head, University Medical Ctr Groningen

• Adjunct Professor, University of Bologna

• Director Immunopeptidomics, University of Lausanne

• Prof Medical Sciences, University of Manchester

• Predoctoral, University of Milan

• Professor, University of Oxford

• Assistant Professor, University of Pittsburgh

• Chair Gene Immunotherapy, University of Regensburg

• Graduate Student, University Of Sheffield

• Associate Professor Oncology, University of Southampton

• Senior PostDoc Research Fellow Antibody & Vaccine Group, University of Southampton

• Head & Professor, University of Tuebingen

• PostDoc, University of Wuerzburg

• Expert, Uppsala Monitoring Ctr

• Chief Development Officer, Urosphere SAS

• Associate Professor, Utrecht University

• Professor, Vaccine Research Institute of San Diego

• Group Head, Valneva SE

• Strategic Market Research Analyst, Varian Medical Systems Inc

• Medical Oncologist, Vilnius University

• Journalist, VJHemOnc

• Study Director, VOXCAN

• CEO, Vyriad

• Principal Investigator, Weizmann Institute Of Science

• Group Leader, Xencor Inc